Beginning July 1, residents across Georgia can pick up HIV prevention medication at their neighborhood pharmacy without first sitting in a doctor’s waiting room, the result of a law that lets pharmacists prescribe PrEP and PEP directly. Senate Bill 195, signed by Gov. Brian Kemp in May, aims to push these drugs into rural counties where clinics are thin and pharmacies are not.
There is a catch buried in the calendar. The state board that must approve pharmacist training has until January 1, 2027, to finish the job, and no one has said yet how pharmacists will be paid for the service. The start date lands months ahead of the machinery meant to make it run.
What Senate Bill 195 Changes at the Pharmacy Counter
For most of Georgia’s history with HIV prevention, getting on PrEP, short for pre-exposure prophylaxis, the daily or long-acting medicine that lowers the risk of contracting HIV, meant finding a prescriber. That usually pointed to a physician or a specialty clinic. The same went for PEP, or post-exposure prophylaxis, the short course taken within 72 hours of a possible exposure.
The new law, sponsored by state Sen. Chuck Hufstetler, a Rome Republican, hands that authority to pharmacists. They can both prescribe and administer the drugs once they clear an approved training program. The bill moved with rare bipartisan ease, clearing the Georgia House on a 155-7 vote in February before Kemp added his signature, recorded among the state’s 2026 signed legislation from the governor’s office.
The statute does not turn a pharmacy into a clinic. It builds guardrails around what a pharmacist can do:
- Training first. A pharmacist must complete a state-approved program covering drug pharmacology, contraindications, financial assistance options, and federal prescribing guidelines.
- A referral every time. Each prescription has to come with a referral to a primary care doctor for follow-up testing and ongoing care.
- Prevention, not treatment. The authority covers HIV prevention drugs, not the management of an existing HIV diagnosis.
The Gap Between the July Start and the Rulebook
Here is where the timing turns awkward. The law takes effect July 1, yet the Georgia Board of Pharmacy has until the first day of 2027 to designate which training programs count. Until that designation exists, a pharmacist has no approved course to complete, and the referral-and-training framework that the law leans on sits half-built.
The reimbursement piece is even further behind. Neither the training details nor a payment model had been released as of late spring, which means many pharmacies could hold back rather than offer a service they cannot bill for. The sequence reads like this:
- February 12, 2026 the Georgia House passes SB 195, 155-7.
- May 2026 Kemp signs the bill into law.
- July 1, 2026 the law formally takes effect.
- January 1, 2027 deadline for the pharmacy board to approve training programs.
Advocates have warned that scope-of-practice changes can stall when the support structure lags, the same pattern that tripped up a separate Georgia health workforce bill that stalled in the state Senate. The Board of Pharmacy publishes licensing and rule updates through its official Georgia Board of Pharmacy portal, where the training designations are expected to appear.
Why Georgia’s HIV Map Points Toward Pharmacies
The urgency behind the law is not abstract. Georgia carries one of the heaviest HIV burdens in the United States, and the geography of that burden is exactly what the pharmacy model is built to attack.
Atlanta, Macon and Savannah post the state’s highest rates, according to the Georgia Department of Public Health, and those urban centers are also where prevention medicine is easiest to find. The trouble lives outside them. While late HIV diagnosis, the kind that raises the risk of progressing to AIDS, has fallen in metro Atlanta, it has climbed in counties beyond the city’s reach.
- 52,528 people were living with HIV in Georgia, a prevalence rate among the highest in the country.
- 608.8 per 100,000 residents, a rate that ranks among the top five states by HIV prevalence.
- A PrEP-to-need ratio near 8, one of the lowest in the nation, signaling that most people who could benefit from the drug are not getting it.
- The rural South holds the worst overlap of high HIV incidence and low PrEP access in the country.
Kayla Quimby-Young, HIV policy coordinator at Georgia Equality, put the logic plainly. Rural Georgia has fewer PrEP access points but more pharmacies, she said, and pharmacies are the common denominator. National-level figures from data trackers such as the AIDSVu Georgia HIV profile and the federal AHEAD HIV indicator dashboard for Georgia have long shown the same rural shortfall.
The Reimbursement Question Hanging Over Pharmacists
A law can grant authority without granting a paycheck. That is the open wound in SB 195. Counseling a patient, screening for contraindications, and writing a referral take time, and a pharmacist who is not reimbursed for that time is being asked to absorb a cost. How many will choose to do so when the start date arrives is the question nobody can answer yet.
Georgia Equality is running a series of workshops ahead of July 1, partly to brief the people the law never names. Quimby-Young argues that preparing pharmacists alone will not be enough; community partners, non-profits, and housing and substance-use providers all touch the same vulnerable populations.
It’s going to take a village, a team of people to make this happen. Whether that be housing, drug usage, or anything like that, we all have intersectionality in how those things overlap.
Quimby-Young said that at one of the group’s pre-launch sessions. The reimbursement gap is the kind of funding question Georgia has wrestled with before, including in the state’s handling of public funds for high-cost drug care, where the rules for who pays arrived well after the need did.
Emory’s Rx for Change Aims to Turn Law Into Access
One effort is trying to close the gap between what the statute permits and what patients actually receive. Emory University’s Rollins School of Public Health is running a pilot called Rx for Change, built with AIDS United, the Black Public Health Academy, and the National Pharmaceutical Association. It launches first in Georgia and Louisiana, two states with high rates of new diagnoses.
The program trains pharmacy teams and strengthens their ties to local community organizations, folding HIV testing, PrEP initiation, and prevention education into routine pharmacy visits. Its potential reach is large. Roughly 90% of Americans live within five miles of a pharmacy, and organizers estimate that pharmacy-based prevention could increase PrEP access points by as much as 80-fold across the Southeast.
Natalie Crawford, an associate professor at Rollins who leads the prevention strategy, frames the pharmacy as a privacy advantage as much as a convenience. “No one knows what you are going in there to get. This is really going to de-stigmatize HIV prevention services,” she said. For a disease where stigma still keeps people away from clinics, a counter where the line could be for cough syrup or for PrEP carries its own quiet value.
How Georgia Lines Up With Other Pharmacist-PrEP States
Georgia is late to a model that other states have road-tested for years. At least 20 states already let pharmacists prescribe or furnish PrEP, and the earliest among them offer a preview of both the promise and the friction Georgia is about to meet.
| State | Year authorized | Pharmacist authority | Supply limit |
|---|---|---|---|
| California | 2019 (SB 159) | Furnish PrEP and PEP independently | Up to 60 days, later raised to 90 |
| Colorado | 2020 | Prescribe under a statewide protocol | Set by protocol |
| Virginia | Statewide protocol | Prescribe with testing confirmation | 90-day supply plus refills |
| Georgia | 2026 (SB 195) | Prescribe and administer, referral required | Training and rules pending |
California, the first to act with Senate Bill 159, later widened its supply window, a reminder that these laws tend to be revised after pharmacists and patients test the limits. National professional groups, including the pharmacist PrEP and PEP authority tracker maintained by NASPA, document how scope and supply rules vary from one state to the next.
If the pharmacy board moves quickly and a payment model takes shape before fall, Georgia’s rural counties could start seeing prevention medicine on local shelves within months. If the training designation drifts toward its 2027 deadline and reimbursement stays unsettled, July 1 becomes a date on paper while the access it promised waits for the rules to catch up.
Frequently Asked Questions
Can I get PrEP at a Georgia pharmacy starting July 1, 2026?
Legally, yes, but in practice it depends on whether your pharmacist has completed approved training and whether the pharmacy offers the service. The law takes effect July 1, while the state board has until January 1, 2027, to designate training programs, so availability may be limited at first.
What is the difference between PrEP and PEP?
PrEP, or pre-exposure prophylaxis, is taken before potential exposure to lower the risk of contracting HIV. PEP, or post-exposure prophylaxis, is an emergency course started within 72 hours after a possible exposure. SB 195 lets Georgia pharmacists prescribe both.
Do I still need to see a doctor if a pharmacist prescribes PrEP?
Yes. The law requires every pharmacist-issued prescription to include a referral to a primary care physician for follow-up, including the regular HIV and health testing that PrEP and PEP users need.
Will insurance cover PrEP prescribed by a pharmacist in Georgia?
Coverage for the medication often exists, but how pharmacists themselves will be reimbursed for the prescribing service had not been finalized as of spring 2026. That unresolved payment question may shape how many pharmacies actually offer it.
Which Georgia pharmacies will offer the service first?
No official list exists yet. Because the model is aimed at areas with few clinics, advocates expect rural and independent pharmacies to be important early adopters, though participation depends on staff training and reimbursement.
Why does Georgia need pharmacist-prescribed HIV prevention?
Georgia has one of the highest HIV burdens in the country, with about 52,528 people living with HIV and a low PrEP-to-need ratio. Rural counties have far fewer prescribing clinics but many pharmacies, making drugstores a practical access point.
Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Decisions about HIV prevention medication, including PrEP and PEP, should be made with a qualified healthcare professional. Program details, training requirements, and reimbursement rules described here are accurate as of publication and may change as the Georgia Board of Pharmacy releases further guidance.
